SWS Hemodialysis Care Co., Ltd. (SHA:688410)
China · Delayed Price · Currency is CNY 9.54
-0.23 (-2.35%)
Sep 28, 2026, 4:00 PM EDT
SWS Hemodialysis Care Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,246 | 4,742 | 3,554 | 6,297 | 3,657 | - | |
Market Cap Growth | -8.93% | 33.42% | -43.55% | 72.17% | - | - |
Enterprise Value | 2,835 | 3,302 | 2,178 | 4,859 | 3,479 | - |
Last Close Price | 9.54 | 10.55 | 7.81 | 13.55 | 7.84 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 19.53 | 32.51 | 50.14 | 32.38 | 61.74 | - |
Forward PE | 20.55 | 32.20 | 16.23 | - | - | - |
PS Ratio | 4.65 | 5.88 | 6.27 | 9.12 | 9.57 | - |
PB Ratio | 2.34 | 2.67 | 2.12 | 3.71 | 2.41 | - |
P/TBV Ratio | 2.50 | 2.84 | 2.26 | 4.00 | 2.45 | - |
P/FCF Ratio | 207.02 | 31.23 | 59.27 | - | 15.70 | - |
P/OCF Ratio | 15.13 | 15.40 | 24.83 | 97.55 | 14.88 | - |
PEG Ratio | - | 0.09 | 0.09 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.10 | 4.09 | 3.84 | 7.04 | 9.11 | - |
EV/EBITDA Ratio | 12.73 | 18.23 | 32.27 | 24.79 | 54.41 | - |
EV/EBIT Ratio | 14.01 | 20.40 | 45.33 | 27.02 | 70.08 | - |
EV/FCF Ratio | 138.24 | 21.74 | 36.31 | - | 14.94 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.08 |
Debt / EBITDA Ratio | 0.01 | 0.01 | 0.04 | 0.03 | 0.33 | 0.87 |
Debt / FCF Ratio | 0.11 | 0.01 | 0.04 | - | 0.09 | 6.73 |
Net Debt / Equity Ratio | -0.78 | -0.85 | -0.83 | -0.82 | -0.96 | -0.36 |
Net Debt / EBITDA Ratio | -6.40 | -8.35 | -20.64 | -7.08 | -22.69 | -4.24 |
Net Debt / FCF Ratio | -68.78 | -9.95 | -23.22 | 28.95 | -6.23 | -29.88 |
Asset Turnover | 0.41 | 0.37 | 0.29 | 0.36 | 0.31 | 0.49 |
Inventory Turnover | 2.63 | 2.44 | 2.13 | 2.52 | 2.22 | 2.44 |
Quick Ratio | 2.96 | 3.59 | 6.51 | 11.06 | 5.09 | 4.68 |
Current Ratio | 3.35 | 4.04 | 7.23 | 12.21 | 5.55 | 5.76 |
Return on Equity (ROE) | 10.47% | 8.34% | 3.79% | 11.97% | 5.97% | 4.78% |
Return on Assets (ROA) | 5.62% | 4.64% | 1.52% | 5.82% | 2.50% | 2.09% |
Return on Invested Capital (ROIC) | 45.16% | 51.30% | 15.17% | 84.54% | 28.38% | 6.69% |
Return on Capital Employed (ROCE) | 10.50% | 8.60% | 2.70% | 10.00% | 3.10% | 3.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.36% | 3.08% | 1.99% | 3.09% | 1.62% | - |
FCF Yield | 0.48% | 3.20% | 1.69% | -0.76% | 6.37% | - |
Dividend Yield | 2.10% | 1.35% | 0.92% | 1.42% | - | - |
Payout Ratio | - | 21.91% | 60.84% | 14.97% | 1.26% | 9.14% |
Buyback Yield / Dilution | 15.24% | 0.55% | 0.51% | -0.01% | -33.27% | -10.50% |
Total Shareholder Return | 17.34% | 1.91% | 1.43% | 1.41% | -33.27% | -10.50% |